BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 29048621)

  • 21. Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
    Lv YF; Dai H; Yan GN; Meng G; Zhang X; Guo QN
    Cancer Lett; 2016 Apr; 373(2):164-73. PubMed ID: 26845447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Snail-induced epithelial-mesenchymal transition in gastric carcinoma cells and generation of cancer stem cell characteristics.
    Yang YJ; Li ZB; Zhang GR; Wu LJ; Yu JY; Hu LJ; Zhou YL; Wang HD; Liang D
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
    Zheng B; Ren T; Huang Y; Guo W
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
    Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
    Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
    Miao JW; Liu LJ; Huang J
    Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex-determining region Y-box protein 3 induces epithelial-mesenchymal transition in osteosarcoma cells via transcriptional activation of Snail1.
    Qiu M; Chen D; Shen C; Shen J; Zhao H; He Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):46. PubMed ID: 28335789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA-XIST promotes the oxidative stress-induced migration, invasion, and epithelial-to-mesenchymal transition of osteosarcoma cancer cells through miR-153-SNAI1 axis.
    Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
    Cell Biol Int; 2020 Oct; 44(10):1991-2001. PubMed ID: 32515520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition.
    Gong C; Shen J; Fang Z; Qiao L; Feng R; Lin X; Li S
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29899166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways.
    Chen H; Pan J; Zhang L; Chen L; Qi H; Zhong M; Shi X; Du J; Li Q
    Eur J Pharmacol; 2018 Apr; 825():133-142. PubMed ID: 29476880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
    Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF
    Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway.
    Fu XT; Dai Z; Song K; Zhang ZJ; Zhou ZJ; Zhou SL; Zhao YM; Xiao YS; Sun QM; Ding ZB; Fan J
    Int J Oncol; 2015 Feb; 46(2):587-96. PubMed ID: 25405790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorogenic acid inhibits osteosarcoma carcinogenesis via suppressing the STAT3/Snail pathway.
    Zhang F; Yin G; Han X; Jiang X; Bao Z
    J Cell Biochem; 2019 Jun; 120(6):10342-10350. PubMed ID: 30582213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells.
    Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H
    Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
    Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
    Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
    Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
    Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.